Stocks · Real Estate · REIT - Healthcare Facilities
Medical Properties Trust, Inc. MPT
$3.27 -2.97% Close, Oct 2, 2026 · NYSE · Market cap $1.96B
Weak trendHigh risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 56.6% from 45.7% a year earlier.
- Net debt is 8.9× EBITDA, a high level of leverage.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 39%
- FCF growth (TTM, YoY)Top 29%
- Revenue growth, 3-year CAGRBottom 5%
- Revenue growth accelerationTop 13%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 49%
- Gross marginTop 11%
- Operating marginTop 14%
- Accruals (lower is better)Bottom 33%
- Net debt / EBITDA (lower is better)Bottom 30%
- Interest coverBottom 32%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 23%
- Free-cash-flow yieldTop 20%
- EBITDA / enterprise valueTop 18%
- Sales / enterprise valueBottom 35%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 17%
- 6-month returnBottom 9%
- 1-year return vs S&P 500Bottom 13%
- Distance from 52-week highBottom 10%
- Trend checklist (0–4)Bottom 22%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 18%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyBottom 37%
- Upside to consensus price targetBottom 27%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 10%
- Maximum drawdown, 3 yearsBottom 31%
- Beta vs S&P 500 (lower is better)Bottom 10%
- Net debt / EBITDA (lower is better)Bottom 30%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.1% | 10.2% | ↑ |
| Gross margin | 96.5% | 82.5% | ↓ |
| Operating margin | 45.7% | 56.6% | ↑ |
| FCF margin | 20.3% | 22.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 10.2% | 5.1% | ↑ | Top 39% |
| Gross margin | 82.5% | 96.5% | ↓ | Top 11% |
| Operating margin | 56.6% | 45.7% | ↑ | Top 14% |
| Net margin | -3.0% | -154.6% | ↑ | — |
| Free-cash-flow margin | 22.3% | 20.3% | ↑ | — |
| Return on invested capital | 3.7% | — | Bottom 49% | |
| Revenue growth, 3-year CAGR | -14.3% | — | Bottom 5% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -110.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 8.85×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 10.55%
- Net buyback yield (TTM)
- 0.49%
- Shareholder yield
- 11.04%
- Share count change, 1 year
- -0.5%
- Share count change, 3-year CAGR
- -0.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -48.8%
- Average 2-day reaction, last 8
- +1.5%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $3.80
- Target vs current price
- +16.2%
- Analysts with a rating
- 28
- Share rating Buy or Strong Buy
- 39%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -241.4% | -11.7% | -11.1% | -14.7% | — |
| Apr 30, 2026 | +97.1% | -3.7% | +1.9% | +0.0% | -6.6% |
| Feb 19, 2026 | +130.4% | +12.1% | +7.3% | -10.6% | -3.5% |
| Oct 30, 2025 | -181.3% | +6.4% | +0.2% | +18.7% | +5.1% |
| Jul 31, 2025 | -11088.8% | -0.2% | +0.7% | +7.0% | +22.5% |
| May 1, 2025 | -233.3% | -6.9% | -8.5% | -16.5% | -22.8% |
| Feb 27, 2025 | -1825.0% | +17.0% | +20.1% | +28.5% | -4.4% |
| Nov 7, 2024 | -770.0% | -1.1% | -4.1% | -9.8% | +4.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.01 | $0.01 | -241.4% | $259.3M |
| Apr 30, 2026 | $0.05 | $0.03 | +97.1% | $252.1M |
| Feb 19, 2026 | $0.03 | $0.01 | +130.4% | $270.3M |
| Oct 30, 2025 | -$0.13 | $0.16 | -181.3% | $237.5M |
| Jul 31, 2025 | -$0.16 | -$0.00 | -11088.8% | $240.4M |
| May 1, 2025 | -$0.20 | $0.15 | -233.3% | $223.8M |
| Feb 27, 2025 | -$0.69 | $0.04 | -1825.0% | $231.8M |
| Nov 7, 2024 | -$1.34 | $0.20 | -770.0% | $225.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 80.1× | — | — | — |
| EV / EBITDA | 10.7× | — | — | Top 18% |
| EV / Sales | 11.05× | — | — | Bottom 35% |
| Free-cash-flow yield | 11.60% | — | — | Top 20% |
| Earnings yield | -1.61% | — | — | Bottom 23% |
P/E over the past five years
Range 5.4× – 69.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -9.4%
- 200-day average slope (20 days)
- -3.6%
- Distance from 50-day average
- -18.7%
- Distance from 200-day average
- -31.6%
- RSI (14)
- 29.2
- Relative volume
- 1.21×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.4%
- Volatility vs own 5-year history
- 52th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.01
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -45.7%
- Maximum drawdown, 3 years
- -48.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 14, 2022 | Jan 17, 2024 | -87.3% | 502 days | Not yet recovered |
| Apr 26, 2021 | Aug 19, 2021 | -13.4% | 81 days | 87 days (Dec 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.96B
- EPS, diluted (TTM)
- -$0.05
- Revenue (TTM)
- $1.02B
- Dividend yield
- 11.01%
- 52-week range
- $3.25 – $6.47
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.54B | $1.54B | $871.8M | $995.5M | $972.0M |
| Gross profit | $1.51B | $1.50B | $830.2M | $968.3M | $935.6M |
| Operating income | $1.04B | $1.00B | $81.3M | $386.8M | $539.8M |
| Net income | $656.0M | $902.6M | -$556.5M | -$2.41B | -$277.0M |
| EPS (diluted) | $1.11 | $1.50 | -$0.93 | -$4.02 | -$0.46 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $225.8M | $235.3M | $223.8M | $240.4M | $237.5M | $270.3M | $252.1M | $259.3M |
| Net income | -$801.2M | -$412.8M | -$118.3M | -$98.4M | -$77.7M | $17.3M | $32.8M | -$2.6M |
| EPS (diluted) | -$1.34 | -$0.69 | -$0.20 | -$0.16 | -$0.13 | $0.03 | $0.05 | -$0.01 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $811.7M | $739.0M | $505.8M | $245.5M | $230.8M |
| Capital expenditure | -$65.5M | -$1.54B | $0 | $0 | $0 |
| Free cash flow | $746.1M | -$801.3M | $505.8M | $245.5M | $230.8M |
| Dividends paid | -$643.5M | -$698.5M | -$615.4M | -$321.1M | -$193.3M |
| Net share buybacks | $1.05B | -$17.9M | -$8.1M | -$3.8M | -$25.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $396.6M
- Total assets
- $14.75B
- Total liabilities
- $10.25B
- Total debt
- $9.70B
- Net debt
- $9.31B
- Shareholders’ equity
- $4.50B
As of Jun 30, 2026 (filed Aug 10, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 10, 2026 | $0.09 | Oct 8, 2026 |
| Jun 18, 2026 | $0.09 | Jul 16, 2026 |
| Mar 12, 2026 | $0.09 | Apr 9, 2026 |
| Dec 11, 2025 | $0.09 | Jan 8, 2026 |
| Sep 11, 2025 | $0.08 | Oct 9, 2025 |
| Jun 18, 2025 | $0.08 | Jul 17, 2025 |
| Mar 10, 2025 | $0.08 | Apr 10, 2025 |
| Dec 12, 2024 | $0.08 | Jan 9, 2025 |
Short interest
- Shares sold short
- 145,296,024
- Days to cover
- 15.13
- Change vs previous report
- -3.2%
FINRA short interest, settlement date Sep 15, 2026.